Rocky Mountain Life Science Investor Conference Announces Final 13 Presenting Companies & Nationally Acclaimed Speakers: Nobel Laureate Dr. Tom Cech and Johnson & Johnson Corporate Development President Roy Davis

DENVER--(Business Wire)--
Organizers of the Inaugural Rocky Mountain Life Science Investor Conference
(RMLIC) have announced the final 13 of 30 presenting companies that will
showcase their innovations to leading investors and industry experts on
September 17 at the Ritz Carlton, Denver. The announcement is made by John
Collar, President & CEO of the Colorado BioScience Association (CBSA), who says
the conference itinerary will also feature nationally acclaimed speakers Nobel
Laureate Dr. Tom Cech and Roy Davis, President J&J Corporate Development.

"Both the Colorado BioScience Association and the Arizona BioIndustry
Association along with our regional partners are simply thrilled to have both
Roy Davis and Dr. Cech present during the Rocky Mountain Life Science Investor
Conference," Collar explains. "This will provide an opportunity for attendees to
hear from two leaders within the industry and show the excitement around the
biosciences that lie within the Rocky Mountain region."

The final 13 of the 30 presenting companies at the RMLIC include:

* Allogenesis - Denver, CO - Website coming soon
* Applied Microarrays, Inc. - Tempe, AZ - www.appliedmicroarrays.com
* Axial Biotech - Salt Lake City, UT - www.axialbiotech.com
* Beacon Biotechnology - Aurora, CO - www.beaconbiotechnology.com
* Castle Biosciences- Phoenix, AZ - www.castlebiosciences.com
* Leap Frogg - Grand Junction, CO - Website coming soon
* LigoCyte Pharmaceuticals - Bozeman, MT - www.ligocyte.com
* Medipacs - Tucson, AZ - www. medipacs.com
* NanoMR - Albuquerque, NM - www.nanomr.com
* Numira Biosciences - Salt Lake City, UT - www.numirabio.com
* PharmaJet - Golden, CO - www.pharmajet.com
* SenesTech, Inc. - Flagstaff, AZ - www.senestech.com
* Western States Biopharmaceuticals - Aurora, CO -
www.westernstatesbiopharm.com

Last month, during the first-round of the RMLIC selection process, the following
17 companies were announced: Apoplogic, Aurora, CO; BioAmps, Aurora, CO;
Biodesix, Broomfield, CO; BiOptix Diagnostics, Boulder, CO; Coherex, Salt Lake
City, UT; GlobeImmune, Louisville, CO; High Throughput Genomics, Tucson, AZ;
Inviragen, Fort Collins, CO; Kinetic Muscles, Tempe, AZ; LineaGen, Salt Lake
City, UT; Medivance, Louisville, CO; mirage, Boulder, CO; Myocept, Lafayette,
CO; Regenesis, Scottsdale, AZ; ThermImage, Salt Lake City, UT; ValveXchange,
Aurora, CO; and Vital Access, Salt Lake City, UT.

More about the inaugural RMLIC

The conference will commence with a breakfast keynote presentation by Roy Davis
who will lend his insight behind the world of biosciences and his expectations
for the bioscience industry and what lies ahead for Johnson & Johnson. He will
also delve into the world of partnerships and the importance of attending
conferences and networking to build relationships and collaboration within the
industry.

Over the last year, the State of Colorado has been anticipating Dr. Tom Cech`s
return to the University of Colorado Boulder and the implementation of the new
Colorado Initiative for Molecular Biology (CIMB). Dr. Cech will provide the
luncheon keynote presentation during the RMILC and give the audience a preview
into his research and what the future holds. The CIMB will be opening its doors
in December of 2011, and during Dr. Cech`s presentation he will be able to
discuss the collaboration and innovation that will generate from this unique
project.

In addition to the two keynote presentations, the RMLIC will showcase two panel
discussions during the day. The first panel, moderated by Dr. Patrick Mahaffy,
President and CEO of Clovis Oncology, will discuss business development inside
the bioscience industry and what peaks the interest of the large biotech,
pharmaceutical and medical device companies.

The second panel will consist of venture capital leaders from across the nation
to provide advice and lessons learned to the participants at the RMLIC. The
Venture Capital Panel will be moderated by Chris Christoffersen, Partner
Morgenthaler Ventures and include Jamie Topper, MD, Partner, Frazier Healthcare
Ventures; Steven Weinstein, Managing Director, Novartis Venture Fund; and Jim
Glasheen, Ph.D., Partner, Technology Partners.

For registration information, visit the conference website at
http://www.rmlic.com.

About Arizona BioIndustry Association

The Arizona BioIndustry Association is a not-for-profit, 501(c)(6) trade
association that seeks to unify, empower and advance its member organizations,
allowing them to benefit individually by acting collectively. AZBio strives to
enhance the environment that makes Arizona a place where bioscience companies
can grow and succeed. AZBio is the state affiliate in Arizona for the
Biotechnology Industry Organization (BIO), the preeminent trade association for
the biotechnology industry in the United States. For more information, visit
http://www.azbio.org.

About Colorado BioScience Association

CBSA is a not-for-profit corporation providing services and support for
Colorado`s growing biosciences industry. With more than 400 members, the CBSA
actively works to promote the growth of the industry by advocating for a better
business environment, by promoting programs that grow the state`s bioscience
workforce, by fighting for policies that support a strong bioscience industry in
the state and by speaking with a single voice on behalf of the companies in the
state. For more information, visit www.cobioscience.com.

Colorado BioScience Association
April Giles, 303-592-4071
Vice President, Administration & Operations
agiles@cobioscience.com
or
Leah Kientz, 303-592-4088
Director of Public Policy and Programs
Lkientz@cobioscience.com
or
Absolutely PR
Maggie Chamberlin Holben, 303-984-9801
maggie@absolutelypr.com
http://www.absolutelypr.com

Copyright Business Wire 2009